Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Berardinelli-Seip congenital lipodystrophy

ORPHA528
Synonym(s) BSCL
Beradinelli-Seip syndrome
Brunzell syndrome
GCL
Generalized congenital lipodystrophy
Lipoatrophic diabetes
Prevalence 1-9 / 1 000 000
Inheritance Autosomal recessive
Age of onset Neonatal
ICD-10
  • E88.1
OMIM
UMLS
  • C0011859
MeSH -
MedDRA
  • 10024603

Summary

Disease definition

Berardinelli-Seip congenital lipodystrophy (BSCL) is characterized by the association of lipoatrophy, hypertriglyceridemia, hepatomegaly and acromegaloid features. BSCL belongs to the group of extreme insulin resistance syndromes, which also includes leprechaunism, Rabson-Mendenhall syndrome, acquired generalized lipodystrophy, and types A and B insulin resistance (see these terms).

Epidemiology

The prevalence of BSCL in the general population of Europe is estimated at 1/400,000.

Clinical description

BSCL is associated with insulin resistance resulting in clinically overt diabetes mellitus with onset during the second decade. Complications include hypertrophic cardiomyopathy, a fatty liver with hepatic dysfunction, muscular hypertrophy, a number of endocrine disturbances (accelerated growth in infancy, precocious puberty etc.) and bone cysts with spontaneous fractures.

Etiology

Two causative genes have been identified: AGPAT2 (9q34), encoding a key enzyme in triglyceride biosynthesis (1-acyl-glycerol-3-phosphate-O-acyltransferase-2), and BSCL2 (11q13), encoding the seipin protein. Intellectual deficit is observed in the majority of patients carrying BSCL2 mutations.

Diagnostic methods

Diagnosis is based on recognition of the clinical picture and associated biochemical disturbances, and may be confirmed by genetic testing.

Differential diagnosis

Differential diagnoses include laminopathies and Parry-Romberg syndrome (see these terms).

Genetic counseling

Transmission is autosomal recessive.

Management and treatment

Treatment consists of a low fat diet, and appropriate management of the insulin resistance and diabetes.

Prognosis

Prognosis depends on the presence of associated complications.

Expert reviewer(s)

  • Pr Lionel VAN MALDERGEM

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Summary information
Guidance for genetic testing
Clinical genetics review
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.